{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:13:01Z","timestamp":1768273981364,"version":"3.49.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cyto.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T09:32:14Z","timestamp":1432891934000},"page":"207-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Update on the role of Interleukin 17 in rheumatologic autoimmune diseases"],"prefix":"10.1016","volume":"75","author":[{"given":"Christine","family":"Konya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sokratis A.","family":"Apostolidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Annals Rheum Diseases"},{"key":"10.1016\/j.cyto.2015.01.003_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7750.2013.13125","article-title":"Systematic review of interleukin-12, interleukin-17, and interleukin-23 pathway inhibitors for the treatment of moderate-to-severe chronic plaque psoriasis: ustekinumab, briakinumab, tildrakizumab, guselkumab, secukinumab, ixekizumab, and brodalumab","volume":"18","author":"Tausend","year":"2014","journal-title":"J. Cutaneous Med Surgery"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/1744666X.2014.878649","article-title":"Ustekinumab for the treatment of psoriatic arthritis","volume":"10","author":"Wofford","year":"2014","journal-title":"Exp Rev Clinical Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0020","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0025","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.cyto.2015.01.003_b0030","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J"},{"issue":"18","key":"10.1016\/j.cyto.2015.01.003_b0035","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/cr.2007.35","article-title":"A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses","volume":"17","author":"Chang","year":"2007","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0045","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheumatism"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02684010","article-title":"Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction","volume":"51","author":"Lubberts","year":"2002","journal-title":"Inflammation Res: Official J Euro Histamine Res Soc [et al]."},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0060","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0065","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4049\/jimmunol.162.3.1246","article-title":"IL-17 is produced by some proinflammatory Th1\/Th0 cells but not by Th2 cells","volume":"162","author":"Aarvak","year":"1999","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0080","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0085","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","article-title":"Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production","volume":"178","author":"Shibata","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0090","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.180.8.5167","article-title":"Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion","volume":"180","author":"Rachitskaya","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0095","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.4049\/jimmunol.179.8.5576","article-title":"Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells","volume":"179","author":"Roark","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukocyte Biol"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0110","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0115","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.4049\/jimmunol.179.8.5462","article-title":"Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F","volume":"179","author":"Kuestner","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2007.11.013","article-title":"Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy","volume":"41","author":"Shen","year":"2008","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4049\/jimmunol.176.2.711","article-title":"Evidence for ligand-independent multimerization of the IL-17 receptor","volume":"176","author":"Kramer","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2015.01.003_b0135","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.4049\/jimmunol.179.10.6379","article-title":"Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor","volume":"179","author":"Kramer","year":"2007","journal-title":"J Immunol"},{"issue":"20","key":"10.1016\/j.cyto.2015.01.003_b0140","doi-asserted-by":"crossref","first-page":"14100","DOI":"10.1074\/jbc.M801357200","article-title":"Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway","volume":"283","author":"Lindemann","year":"2008","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0145","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"New England J Med"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0155","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0170","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.smim.2007.10.015","article-title":"Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation","volume":"19","author":"Chen","year":"2007","journal-title":"Seminars Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ni1022","article-title":"An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells","volume":"5","author":"Eberl","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.cyto.2015.01.003_b0190","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0195","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni1500","article-title":"The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4","volume":"8","author":"Brustle","year":"2007","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0200","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.01.003_b0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annual Rev Immunol"},{"issue":"7090","key":"10.1016\/j.cyto.2015.01.003_b0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"7090","key":"10.1016\/j.cyto.2015.01.003_b0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"6924","key":"10.1016\/j.cyto.2015.01.003_b0225","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0230","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0240","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","article-title":"IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor","volume":"29","author":"Chen","year":"2008","journal-title":"Immunity"},{"issue":"52","key":"10.1016\/j.cyto.2015.01.003_b0245","doi-asserted-by":"crossref","first-page":"20846","DOI":"10.1073\/pnas.0809077106","article-title":"IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype","volume":"105","author":"Huber","year":"2008","journal-title":"Proc National Acad Sci United States of America"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.0105-2896.2009.00864.x","article-title":"IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?","volume":"233","author":"Biswas","year":"2010","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0255","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0270","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.immuni.2011.02.011","article-title":"Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2","volume":"34","author":"Chen","year":"2011","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0275","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T helper lymphocytes","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.cyto.2015.01.003_b0280","first-page":"307","article-title":"The role of epigenetic mechanisms and processes in autoimmune disorders","volume":"6","author":"Greer","year":"2012","journal-title":"Biol: Targets Ther"},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0285","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/art.1780331109","article-title":"Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis","volume":"33","author":"Richardson","year":"1990","journal-title":"Arthritis Rheumatism"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0290","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1074\/jbc.C600322200","article-title":"Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation","volume":"282","author":"Akimzhanov","year":"2007","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"10.1016\/j.cyto.2015.01.003_b0295","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.drudis.2011.03.009","article-title":"Histone acetyltransferases are crucial regulators in NF-kappaB mediated inflammation","volume":"16","author":"Ghizzoni","year":"2011","journal-title":"Drug Discovery Today"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0300","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1165\/ajrcmb.25.3.4424","article-title":"Interleukin-17 and lung host defense against Klebsiella pneumoniae infection","volume":"25","author":"Ye","year":"2001","journal-title":"Am J Respiratory Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0310","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1128\/IAI.01026-13","article-title":"Nlrp-3-driven interleukin 17 production by gammadeltaT cells controls infection outcomes during Staphylococcus aureus surgical site infection","volume":"81","author":"Maher","year":"2013","journal-title":"Infection Immunity"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0315","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.1303420","article-title":"Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection","volume":"192","author":"Murphy","year":"2014","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0320","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.170.4.2106","article-title":"IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger","volume":"170","author":"Ferretti","year":"2003","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/cyto.1998.0433","article-title":"Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway","volume":"11","author":"Shin","year":"1999","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0330","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-010-9369-6","article-title":"The IL-17 family cytokines in immunity and disease","volume":"30","author":"Pappu","year":"2010","journal-title":"J Clin Immunol"},{"issue":"47","key":"10.1016\/j.cyto.2015.01.003_b0345","doi-asserted-by":"crossref","first-page":"35603","DOI":"10.1074\/jbc.C600256200","article-title":"Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor","volume":"281","author":"Chang","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0350","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2015.01.003_b0355","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.61.10.870","article-title":"Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro","volume":"61","author":"Van Bezooijen","year":"2002","journal-title":"Annals Rheumatic Diseases"},{"key":"10.1016\/j.cyto.2015.01.003_b0360","first-page":"65","article-title":"Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis","author":"Koenders","year":"2006","journal-title":"Annals Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0365","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0370","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","article-title":"Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1","volume":"167","author":"Koenders","year":"2005","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.cyto.2015.01.003_b0380","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/art.30418","article-title":"Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis","volume":"63","author":"Koenders","year":"2011","journal-title":"Arthritis Rheumatism"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0385","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","article-title":"Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA","volume":"30","author":"Metawi","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0390","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheumatism"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0395","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/1529-0131(200109)44:9<2078::AID-ART358>3.0.CO;2-J","article-title":"Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci","volume":"44","author":"LeGrand","year":"2001","journal-title":"Arthritis Rheumatism"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0400","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1462-5822.2010.01559.x","article-title":"Inducible NO synthase and antibacterial host defence in times of Th17\/Th22\/T22 immunity","volume":"13","author":"Muhl","year":"2011","journal-title":"Cell Microbiol"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0405","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","article-title":"Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23","volume":"191","author":"Paulissen","year":"2013","journal-title":"J. Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0410","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2249.2000.01199.x","article-title":"IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts","volume":"120","author":"Katz","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2015.01.003_b0415","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3899\/jrheum.080169","article-title":"Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis","volume":"36","author":"Lee","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0420","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11926-009-0051-z","article-title":"The role of toll-like receptors in rheumatoid arthritis","volume":"11","author":"Huang","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0425","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2815","article-title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.cyto.2015.01.003_b0430","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/ar4179","article-title":"IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation","volume":"15","author":"Lee","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0435","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0440","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23\/IL-17 axis in lupus nephritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2015.01.003_b0445","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.4049\/jimmunol.0903595","article-title":"Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL\/6-lpr\/lpr mice","volume":"184","author":"Kyttaris","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2015.01.003_b0450","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J Immunol"},{"issue":"7128","key":"10.1016\/j.cyto.2015.01.003_b0455","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.cyto.2015.01.003_b0460","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0465","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2015.01.003_b0470","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.cyto.2015.01.003_b0475","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.4049\/jimmunol.180.11.7423","article-title":"Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes","volume":"180","author":"Pene","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0480","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"9625","key":"10.1016\/j.cyto.2015.01.003_b0485","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"issue":"9625","key":"10.1016\/j.cyto.2015.01.003_b0490","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"issue":"9894","key":"10.1016\/j.cyto.2015.01.003_b0495","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0500","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Annals Rheumatic Diseases"},{"issue":"52","key":"10.1016\/j.cyto.2015.01.003_b0505","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0510","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12110","article-title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","volume":"168","author":"Papp","year":"2013","journal-title":"Brit J Dermatol"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.003_b0515","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/bjd.12070","article-title":"Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study","volume":"168","author":"Rich","year":"2013","journal-title":"Brit J Dermatol"},{"issue":"3","key":"10.1016\/j.cyto.2015.01.003_b0520","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3899\/jrheum.130637","article-title":"One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study","volume":"41","author":"Genovese","year":"2014","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.cyto.2015.01.003_b0525","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study","volume":"72","author":"Genovese","year":"2013","journal-title":"Annals Rheumatic Diseases"},{"issue":"13","key":"10.1016\/j.cyto.2015.01.003_b0530","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"New England J Med"},{"issue":"7","key":"10.1016\/j.cyto.2015.01.003_b0535","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T23:47:27Z","timestamp":1691711247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1043466615000071"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the role of Interleukin 17 in rheumatologic autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}